Abiologics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://abiologics.com/

Last Round

VC Round

Jul 23, 2024

Company Overview

Abiologics is a biotechnology company that develops a platform for designing and synthesizing supranatural biologics, known as Synteins, using generative artificial intelligence and non-standard amino acids.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryprotein engineeringbiotechgenerative AIcomputational biologybiologicsAI drug discoveryin silico drug designtherapeutic developmenthigh-throughput synthesisbiotech platformdrug pipelineprotein designpharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abiologics Comparables

Compare Abiologics with similar companies based on industry and business-model similarity.

Abiologics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nabla Bio	89%
Accipiter Biosciences	86%
AI Proteins	86%

View all Comparables

Abiologics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 23, 2024

View all Funding Rounds

Abiologics Investors

Notable investors and investment history

Abiologics investors
Investor	Rounds
Flagship Pioneering	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 3, 2026
Monthly visitors increased 34% MoM.
Nov 14, 2025
Grew 21% QoQ from 19 to 23 employees.

View all signals

Abiologics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Abiologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abiologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range24

Year Founded2021

Last FundingJul 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.